SeaBridge Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

SeaBridge Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-100	Closed	-$3K	–	267
2017 Q2	$3K	Hold	100	–	–	﹤0.01%	254
2017 Q1	$3K	Hold	100	–	–	﹤0.01%	249
2016 Q4	$4K	Hold	100	–	–	﹤0.01%	240
2016 Q3	$5K	Hold	100	–	–	﹤0.01%	245
2016 Q2	$5K	Hold	100	–	–	﹤0.01%	253
2016 Q1	$5K	Hold	100	–	–	﹤0.01%	224
2015 Q4	$7K	Hold	100	–	–	﹤0.01%	212
2015 Q3	$6K	Hold	100	–	–	﹤0.01%	212
2015 Q2	$6K	Buy	+100	New	+$6.17K	﹤0.01%	208

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

SeaBridge Investment Advisors's TEVA Position: Q3 2017 in Review

SeaBridge Investment Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2017, closing a stake of 100 shares — an estimated $3K sold.

SeaBridge Investment Advisors first reported a position in TEVA in Q2 2015 and held it in 9 quarters. The position peaked at $7K in Q4 2015. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

SeaBridge Investment Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2017 after selling out during the quarter.
SeaBridge Investment Advisors sold 100 Teva Pharmaceutical Industries Limited shares in Q3 2017, an estimated $3K.
SeaBridge Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2015 and held it in 9 quarters.
SeaBridge Investment Advisors's Teva Pharmaceutical Industries Limited position peaked at $7K in Q4 2015.
537 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2017.

Based on SeaBridge Investment Advisors's 13F filing for Q3 2017, filed 19 Oct 2017.